Search Results - "OUWEHAND, Mariët"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice by Bardelmeijer, Heleen A, Ouwehand, Mariët, Beijnen, Jos H, Schellens, Jan H M, van Tellingen, Olaf

    Published in Investigational new drugs (01-08-2004)
    “…P-glycoprotein inhibitors can increase the oral bioavailability of paclitaxel. We have now explored the mechanisms that determine the efficacy of several novel…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography by Vries, Nienke A. de, Ouwehand, Mariët, Buckle, Tessa, Beijnen, Jos H., van Tellingen, Olaf

    Published in Biomedical chromatography (01-11-2007)
    “…A sensitive and selective reversed‐phase high‐performance liquid chromatographic (HPLC) assay has been developed and validated for quantification of total…”
    Get full text
    Journal Article
  4. 4

    Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir by BARDELMEIJER, Heleen A, OUWEHAND, Mariët, BUCKLE, Tessa, HUISMAN, Maarten T, SCHELLENS, Jan H. M, BEIJNEN, Jos H, VAN TELLINGEN, Olaf

    Published in Cancer research (Chicago, Ill.) (01-11-2002)
    “…P-glycoprotein seems to be the most important factor limiting the oral absorption of paclitaxel. We have now explored the mechanisms responsible for the low…”
    Get full text
    Journal Article
  5. 5

    Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut by BARDELMEIJER, Heleen A, OUWEHAND, Mariët, MALINGRE, Mirte M, SCHELLENS, Jan H. M, BEIJNEN, Jos H, VAN TELLINGEN, Olaf

    Published in Cancer chemotherapy and pharmacology (01-02-2002)
    “…Recent studies in mice and patients have shown that the low oral bioavailability of paclitaxel can be increased by coadministration of P-glycoprotein blockers…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype by Beumer, Jan-Hendrik, Buckle, Tessa, Ouwehand, Mariet, Franke, Niels E F, Lopez-Lazaro, Luis, Schellens, Jan H M, Beijnen, Jos H, van Tellingen, Olaf

    Published in Investigational new drugs (01-02-2007)
    “…Trabectedin (ET-743, Yondelis) is a novel anticancer drug currently undergoing phase II and III investigations. There are various and conflicting reports…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Determination of cyclosporin A in human and mouse plasma by reversed-phase high-performance liquid chromatography by Bardelmeijer, Heleen A., Ouwehand, Mariët, Beijnen, Jos H., Schellens, Jan H.M., van Tellingen, Olaf

    “…An isocratic reversed-phase high-performance liquid chromatographic method with ultraviolet detection at 227 nm has been validated for the determination of…”
    Get full text
    Journal Article